Taken together, these results place EGFR as a mediator of ETV1 oncogenic activity both in early and advanced prostate carcinogenesis, while ERG overexpression seems to indirectly repress EGFR activation in early PCa carcinogenesis. Here, EGFR is linked to posterior cortical atrophy.